I-0482 for COVID-19

 I-0482 has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed I-0482 in detail.
De, S., Recent Discovery of Triazine Derivatives as Protease Inhibitors for the Treatment of Coronavirus-19 (COVID-19), Current Organic Synthesis, doi:10.2174/1570179420666230320120852
Abstract: The present application describes a class of compounds exhibiting a coronavirus 3CL protease inhibitory effect and pharmaceutically acceptable salts thereof, and a pharmaceutical composition containing the same. The application also provides the synthesis of compounds and efficacy from in vitro and cell- based assays.